Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Segall

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Vascular Pharmacology|November 8, 2005
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitroM Ramos, M W Lamé, H J Segall, et al.
Cell|October 1, 1979
Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNAP A Weil, D S Luse, J Segall, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Metabolism of [14C]monocrotaline by isolated perfused rat liverM W Lamé, A D Jones, D Morin, et al.
Toxicology and Applied Pharmacology|January 6, 1999
Alteration in lung particle translocation, macrophage function, and microfilament arrangement in monocrotaline-treated ratsA K Madl, D W Wilson, H J Segall, et al.
Archives of Biochemistry and Biophysics|April 1, 1992
Quantification of cytochrome P450 reductase gene expression in human tissuesE A Shephard, C N Palmer, H J Segall, et al.
Toxicology and Applied Pharmacology|November 1, 1996
Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNAH C Thomas, M W Lamé, D W Wilson, et al.
Toxicology and Applied Pharmacology|July 18, 2000
DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cellsD W Wilson, M W Lamé, S K Dunston, et al.
Science (New York, N.Y.)|August 2, 1985
trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionineH J Segall, D W Wilson, J L Dallas, et al.
Microvascular Research|July 1, 1989
Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated ratsD W Wilson, H J Segall, L C Pan, et al.
Toxicologic Pathology|March 28, 2008
Smad signaling in the rat model of monocrotaline pulmonary hypertensionMargaret F Ramos, Michael W Lamé, Henry J Segall, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Vascular Pharmacology|November 8, 2005
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitroM Ramos, M W Lamé, H J Segall, et al.
Cell|October 1, 1979
Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNAP A Weil, D S Luse, J Segall, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Metabolism of [14C]monocrotaline by isolated perfused rat liverM W Lamé, A D Jones, D Morin, et al.
Toxicology and Applied Pharmacology|January 6, 1999
Alteration in lung particle translocation, macrophage function, and microfilament arrangement in monocrotaline-treated ratsA K Madl, D W Wilson, H J Segall, et al.
Archives of Biochemistry and Biophysics|April 1, 1992
Quantification of cytochrome P450 reductase gene expression in human tissuesE A Shephard, C N Palmer, H J Segall, et al.
Toxicology and Applied Pharmacology|November 1, 1996
Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNAH C Thomas, M W Lamé, D W Wilson, et al.
Toxicology and Applied Pharmacology|July 18, 2000
DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cellsD W Wilson, M W Lamé, S K Dunston, et al.
Science (New York, N.Y.)|August 2, 1985
trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionineH J Segall, D W Wilson, J L Dallas, et al.
Microvascular Research|July 1, 1989
Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated ratsD W Wilson, H J Segall, L C Pan, et al.
Toxicologic Pathology|March 28, 2008
Smad signaling in the rat model of monocrotaline pulmonary hypertensionMargaret F Ramos, Michael W Lamé, Henry J Segall, et al.
Pageof 14